Zevra Therapeutics, Inc. ( ZVRA) - Stock Earnings
ZVRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
ZVRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 12.2 million USD | 34.1 million USD |
| 2026Q1 | 37.9 million USD | 36.2 million USD |
| 2026Q2 | 8.8 million USD | 39.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ZVRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -46.0 million USD | 27.5 million USD |
| 2024 | -105.5 million USD | 23.6 million USD |
| 2025 | 83.2 million USD | 106.5 million USD |
| 2026 Est. | — | — |
ZVRA
Price: $9.94
52 week price:
Earnings Per Share: 0.93 USD
P/E Ratio: 12.19
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 590.6 million